Dexcom G6 for Total Pancreatectomy With Islet Autotransplantation (TPIAT) Patients

Deborah Elder

Status: Completed

Conditions: Diabetes

Treatments: Other: Uncovered CGM during radiologic procedures

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT05607576

2021-0838

Details and patient eligibility

About

A single-center prospective trial on the effects of standard of care radiation exposure on the Dexcom G6 continuous glucose monitoring (CGM) device.

Full description

To determine if standard of care radiation exposure longitudinally effects the accuracy and precision of the G6 transmitter in the post TPIAT in-patient population.

Reduce burden for patients to remove and waste a functional and expensive Dexcom G6 CGM for radiologic procedures.

Enrollment: 18 patients

Sex: All

Ages: 11 to 25 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Planned TPIAT at CCHMC
• Staying in-patient at CCHMC post TPIAT
• Planned to receive a Dexcom G6 CGM

Exclusion criteria

• Hemo- or peritoneal dialysis

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

18 participants in 1 patient group

Uncovered

Experimental group

Description:

Dexcom G6 CGM will be uncovered during standard of care radiologic procedures.

Treatment:

Other: Uncovered CGM during radiologic procedures